Eton Pharmaceuticals, Inc.

NASDAQ:ETON

Biotechnology

Healthcare
$61.99 -1.39%

-$0.46 today

Market cap
$1.79B
Beta
0.89
P/E (TTM)
-597.6
EPS (TTM)
-$0.05
52W Low $13.09High $35.66

Volume 0.48M

Average 0.43M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$10.52M

FY 2025 · Annual

+986.1% YoY

Investing Cash Flow

-$333,000.00

FY 2025 · Annual

Financing Cash Flow

$815,000.00

FY 2025 · Annual

-97.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(1.96M)(9.02M)(936K)(3.82M)(4.6M)
Depreciation & Amortization462K1.77M901K1.15M4.04M
Deferred Income Tax(546K)0000
Stock-Based Compensation3.38M4.22M3.14M3.17M5.51M
Change in Working Capital(6.21M)7.66M3.53M(698K)(859K)
Accounts Receivables(5.42M)3.62M(1.56M)(3.12M)(6.4M)
Inventory692K(7K)(354K)(1.31M)(5.88M)
Accounts Payables(570K)(8K)53K2.32M6.81M
Other Working Capital(910K)4.06M5.39M1.41M4.61M
Other Non-Cash Items148K189K184K1.18M6.43M
Operating Cash Flow(4.72M)4.82M6.82M969K10.52M
Capital Expenditures(3.26M)(2.79M)(775K)(26K)(333K)
Acquisitions (Net)700K00(30M)0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities0(2.75M)0(9.99M)0
Investing Cash Flow(2.56M)(2.79M)(775K)(40.01M)(333K)
Debt Repayment(150K)(385K)(1.16M)24.15M0
Common Stock Issued541K008.19M598K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0251K198K248K217K
Financing Cash Flow391K(134K)(957K)32.59M815K
Effect of Forex Changes00000
Net Change in Cash(6.89M)1.9M5.08M(6.45M)11.01M
Free Cash Flow(7.98M)2.03M6.04M943K10.19M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$4.6M
+ D&A$4.0M
+ Stock-Based Comp$5.5M
+ Deferred Tax$0
- Working Capital-$859.0K
+ Other Non-Cash$6.4M
= Operating Cash Flow$10.5M
- Capex-$333.0K
= Free Cash Flow$10.2M

Analysis

FY2025 free cash flow is $10.2M. FCF conversion is -221.5% of net income. Operating cash flow was $10.5M, with capex of -$333.0K. The largest bridge item is Other Non-Cash at $6.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

Does ETON generate free cash flow?

Eton Pharmaceuticals, Inc. (ETON) generated $10.19M of free cash flow in fiscal 2025.

How much operating cash flow does ETON produce?

Operating cash flow was $10.52M, before capital expenditures of $333,000.00.